Dose Response Bioavailability of Coffee and Green Tea Antioxidants in Humans

NCT ID: NCT01089920

Last Updated: 2014-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Coffee and green tea are 2 widely consumed beverages. Both contain polyphenol antioxidant compounds (chlorogenic acids for coffee and catechins for tea). The bioavailability of catechins is somewhat known and has been referenced in the literature. However, bioavailability data from tea infusion is non-existent, even though it reflects better how consumers drink this beverage. In addition, bioavailability of coffee chlorogenic acids is less understood and no dose response study has been reported so far in the literature. Thus, there is a great need to understand and reinforce our knowledge on the bioavailability of coffee and tea polyphenol compounds.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High dose coffee

High dose of polyphenols from soluble coffee

Group Type EXPERIMENTAL

Coffee

Intervention Type OTHER

Soluble coffee commercially available

Medium dose coffee

Medium dose of polyphenols from soluble coffee

Group Type EXPERIMENTAL

Coffee

Intervention Type OTHER

Soluble coffee commercially available

Low dose coffee

Low dose of polyphenols from soluble coffee

Group Type EXPERIMENTAL

Coffee

Intervention Type OTHER

Soluble coffee commercially available

High dose green tea

High dose of green tea polyphenols from infusion

Group Type EXPERIMENTAL

Green tea

Intervention Type OTHER

Infusion (tea bags) from commercially available green tea

Medium dose green tea infusion

Medium dose of green polyphenols from infusion

Group Type EXPERIMENTAL

Green tea

Intervention Type OTHER

Infusion (tea bags) from commercially available green tea

Low dose green tea infusion

low dose of polyphenols from an infusion of green tea

Group Type EXPERIMENTAL

Green tea

Intervention Type OTHER

Infusion (tea bags) from commercially available green tea

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Green tea

Infusion (tea bags) from commercially available green tea

Intervention Type OTHER

Coffee

Soluble coffee commercially available

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Soluble coffee

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 - 65 years, male and female
* Healthy as determined by the medical questionnaire and the medical visit
* Normal weight: BMI 18 - 25
* Coffee drinkers with an average consumption of 2-5 cups per day
* Having given informed consent

Exclusion Criteria

* Intestinal or metabolic diseases / disorders such as diabetic, renal, hepatic, hypertension, pancreatic or ulcer
* Have had a gastrointestinal surgery, except appendicectomy
* Difficulty to swallow
* Have a regular consumption of medication
* Have taken antibiotic therapy within the last 6 months
* Alcohol consumption \> 2 units a day
* Smokers (more than 5 cigarettes per day)
* Have given blood within the last 3 weeks
* Volunteers who cannot be expected to comply with treatment
* Currently participating or having participated in another clinical trial during the last 3 weeks
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maurice Beaumont, M.D., Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Nestec

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nestle Research Center

Lausanne, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

09.06.MET

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Interindividual Variation in Response to Green Coffee
NCT06204445 ACTIVE_NOT_RECRUITING NA
Coffee and In-vivo Oxidative Stress
NCT00868205 COMPLETED PHASE2